Canada’s Drug Agency recommends funding this drug for early-stage Alzheimer’s disease CTV NewsHistoric Step for Alzheimer’s Care in Canada: CDA-AMC Recognizes Clinical Value of LEQEMBI® (lecanemab) and Recommends Public Coverage for Early Alzheimer’s Disease PR Newswire CanadaCanada’s Drug Agency reverses course, now recommends public drug plans cover Alzheimer’s drug The Globe and MailCanada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease The SpecFund early-stage Alzheimer’s treatment: agency Yahoo News Canada
